iSpecimen Inc. Increase (Decrease) in Interest Payable, Net
iSpecimen Inc. (ISPC) reported Increase (Decrease) in Interest Payable, Net of -$8.17 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2024-03-13
- iSpecimen Inc. increase (decrease) in interest payable, net for the quarter ending 2022-12-31 was -$7.78K, a 1283.87% decline year-over-year.
- iSpecimen Inc. increase (decrease) in interest payable, net for the quarter ending 2022-09-30 was $0.00.
- iSpecimen Inc. increase (decrease) in interest payable, net for the quarter ending 2021-12-31 was $657.00, a 99.89% decline year-over-year.
- iSpecimen Inc. increase (decrease) in interest payable, net for the quarter ending 2021-09-30 was -$2.35K, a 100.50% decline year-over-year.
- iSpecimen Inc. increase (decrease) in interest payable, net for fiscal 2022 was -$8.17K.
- iSpecimen Inc. increase (decrease) in interest payable, net for fiscal 2021 was -$1.71M, a 187.57% decline from fiscal 2020.
- iSpecimen Inc. increase (decrease) in interest payable, net for fiscal 2020 was $1.95M.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$7.78K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$7.78K derived: sum of 2 quarters · filed 2024-03-13 | -$8.17K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$389.00 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | -$389.00 10-Q · filed 2023-08-02 | |||
| 2021-12-31 | $657.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.70K derived: sum of 2 quarters · filed 2023-03-30 | -$2.27M derived: sum of 3 quarters · filed 2023-03-30 | -$1.71M 10-K/A · filed 2023-03-30 |
| 2021-09-30 | -$2.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$2.27M derived: sum of 2 quarters · filed 2022-11-08 | -$1.71M 10-Q · filed 2022-11-08 | -$1.13M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.71M 10-Q · filed 2022-08-04 | -$1.13M derived: sum of 3 quarters · filed 2022-08-04 | -$662.27K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $562.19K 10-Q · filed 2022-05-10 | $1.14M derived: sum of 2 quarters · filed 2022-05-10 | $1.61M derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $577.29K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.04M derived: sum of 2 quarters · filed 2022-03-22 | $1.95M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $467.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.37M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $906.48K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |